Artiva Biotherapeutics

Artiva Biotherapeutics

NK cell therapy for cancer patients. Learn more

Launch date
Employees
Market cap
CAD330m
Enterprise valuation
CAD288m (Public information from Sep 2024)
San Diego California (HQ)
Authorizing premium user...